spacer
home > pmps > summer 2002 > speeding time to market
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Speeding Time to Market

Colleen, perhaps you could start by giving a brief overview of Honeywell?

Honeywell is a US$25 billion diversified technology and manufacturing leader, providing customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; power generation systems; speciality chemicals; fibres; plastics; and electronic and advanced materials.

The company is well over 100 years old and operates with 120,000 employees in approximately 95 countries. Honeywell's Chemicals, Life Sciences and CPG business is a part of Honeywell Industry Solutions, a global business in the Honeywell Automation and Control Solutions (ACS) group, which recently brought together two control systems businesses: Industrial Control and Home and Building Control.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Patricia Lobo of PMPS speaks to Colleen Ellis, Director of Strategy, Alliances and Channel Development; Martin Atkinson, Business Manager for Northern Europe, UK and Ireland; and Benjamin Bryant, Leader, Global Marketing Communications at Honeywell's Automated Control Solutions Division - Chemicals, Life Sciences and Consumer Goods
spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) a subsidiary of WuXi AppTec and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Migration safe pharmaceutical labels improve patient safety

UPM Raflatac

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement